AU3237193A - S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof - Google Patents

S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof

Info

Publication number
AU3237193A
AU3237193A AU32371/93A AU3237193A AU3237193A AU 3237193 A AU3237193 A AU 3237193A AU 32371/93 A AU32371/93 A AU 32371/93A AU 3237193 A AU3237193 A AU 3237193A AU 3237193 A AU3237193 A AU 3237193A
Authority
AU
Australia
Prior art keywords
nitrosothiols
smooth muscle
therapeutic uses
muscle relaxants
relaxants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32371/93A
Inventor
Robert Brown
Jeffrey Drazen
Joseph Loscalzo
Daniel Simon
Adam Slivka
Jonathan Stamler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/943,834 external-priority patent/US5380758A/en
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU3237193A publication Critical patent/AU3237193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU32371/93A 1991-12-11 1992-12-07 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof Abandoned AU3237193A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80466591A 1991-12-11 1991-12-11
US804665 1991-12-11
US07/943,834 US5380758A (en) 1991-03-29 1992-09-14 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
US943834 1992-09-14

Publications (1)

Publication Number Publication Date
AU3237193A true AU3237193A (en) 1993-07-19

Family

ID=27122712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32371/93A Abandoned AU3237193A (en) 1991-12-11 1992-12-07 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof

Country Status (2)

Country Link
AU (1) AU3237193A (en)
WO (1) WO1993012068A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1875917A3 (en) * 1990-12-05 2012-11-28 The General Hospital Corporation Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US5823180A (en) * 1995-04-03 1998-10-20 The General Hospital Corporation Methods for treating pulmonary vasoconstriction and asthma
US6197745B1 (en) * 1995-09-15 2001-03-06 Duke University Methods for producing nitrosated hemoglobins and therapeutic uses therefor
US6916471B2 (en) 1995-09-15 2005-07-12 Duke University Red blood cells loaded with S-nitrosothiol and uses therefor
US6911427B1 (en) 1995-09-15 2005-06-28 Duke University No-modified hemoglobins and uses therefore
US6153186A (en) * 1995-09-15 2000-11-28 Duke University Medical Center Red blood cells loaded with S-nitrosothiol and uses therefor
US6855691B1 (en) 1995-09-15 2005-02-15 Duke University Methods for producing and using S-nitrosohemoglobins
US5994294A (en) * 1996-02-02 1999-11-30 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5824669A (en) 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
EP0941086A4 (en) * 1996-11-01 2000-07-12 Nitromed Inc Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
EP0979073A4 (en) * 1997-03-31 2004-04-07 Childrens Medical Center Nitrosylation to inactivate apoptotic enzymes
GB9720797D0 (en) * 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
EP1263428A2 (en) * 2000-01-18 2002-12-11 Buhimschi, Irina Free radical scavengers for the treatment of premature birth
EP2944648B1 (en) * 2001-03-29 2019-11-13 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for the treatment of organ inflammation
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2998314B1 (en) 2007-06-04 2020-01-22 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2373296B1 (en) 2008-12-03 2016-08-03 Synergy Pharmaceuticals Inc. Formulations of guanylate cyclase c agonists and methods of use
WO2012037380A2 (en) 2010-09-15 2012-03-22 Synergy Pharmaceuticals Inc. Formulations of guanylate cyclase c agonists and methods of use
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2328709A (en) * 1940-06-27 1943-09-07 Socony Vacuum Oil Co Inc Method for stabilizing organic thionitrites

Also Published As

Publication number Publication date
WO1993012068A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
AU3237193A (en) S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof
GB9118670D0 (en) Surgical devices and uses thereof
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
IL105930A0 (en) Therapeutic respiration device
IL109094A0 (en) Human tnf muteins
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
CY2508B1 (en) Benzopyrans and their use as therapeutic agents
EP0518818A3 (en) Arylethers, their manufacture and use as medicament
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
SG42865A1 (en) Therapeutic compositions and methods
AU5223096A (en) Insecticidal composition and insecticidal units
AU5737494A (en) Human thrombospondin-4
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
AU1880792A (en) Benzothiazepinones and their use as anticonvulsants
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
ZA944187B (en) Ipsapirone medicament formulation
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
AU3053595A (en) Therapeutic treatment and preparations
GB9523066D0 (en) Compounds and their therapeutic use
AU6731594A (en) Medical treatment and preparation
ZA945962B (en) Therapeutic formulation
GB9323487D0 (en) Therapeutic formulation
AUPM444294A0 (en) Improvements to medical and therapeutic bandages and the like